Two clinical studies open up new perspectives for the functional use of Montmorency tart cherries in inflammation prevention and metabolic health management.
Until recently, tart cherries – particularly the Montmorency variety – were mainly known in the sports world for their benefits on muscle recovery.
Today, however, new clinical studies reveal their potential in counteracting systemic inflammation and supporting metabolism.
In two recent studies conducted on healthy subjects, researchers investigated the effect of supplementation with concentrated tart cherry extracts on certain biomarkers related to oxidative stress and inflammation.
The first study – a randomized, double-blind, placebo-controlled clinical trial – involved 25 adults with slightly elevated fasting uric acid levels.
Participants consumed a dose of concentrated Montmorency tart cherry powder (CherryPURE®) together with a purine-rich meal, in order to assess potential effects on blood glucose and inflammation.
The results showed no significant effect on postprandial uric acid levels, but a 4.2% reduction in post-meal blood glucose compared to placebo was observed, along with slight changes in the levels of certain inflammatory cytokines.
The second study, also randomized and placebo-controlled, used a standardized European tart cherry extract (NordicCherry®).
Ten healthy subjects took 500 mg per day of the extract for four weeks.
At the end of the intervention, a significant reduction of 37.4% in urate levels and a 23% decrease in C-reactive protein (CRP), a biomarker of systemic inflammation, were observed.
According to the researchers, regular intake of the extract showed a tangible impact on reducing inflammation and regulating uric acid metabolism, suggesting a potential role for tart cherries in the prevention of chronic inflammation and the promotion of metabolic health.
While the first study suggests modest and limited effects, the second provides stronger evidence in support of tart cherries as a functional ingredient capable of contributing to systemic well-being, even in healthy individuals.
Thanks to their polyphenol content, tart cherries are confirmed not only as beneficial for physical recovery, but also as a promising daily support in the prevention of mild inflammatory and metabolic conditions.
A natural ally for those who view nutrition as a key to long-term health.
Source: www.supplysidesj.com
Image source: Onlymyhealth.com
31 Dec 2024
The numbers speak for themselves: thanks to your interest, our analyses and in-depth articles have achieved extraordinary results. This article is dedicated to the content you loved the most: from the most thorough analyses to thematic insights.
26 Jan 2026
The 2025/26 cherry season in China is marked by high volumes, strong logistical pressure and a rapid fall in prices. Chinese buyers are becoming more selective, penalising early fruit and challenging traditional Chilean export models and established commercial strategies.
22 Sep 2026
A Chilean study on Lapins and Regina cherries tests melatonin before and after harvest: greener stems and delayed ripening, but no improvement in firmness and a higher incidence of orange peel disorder, limiting its technical and commercial use for long-distance shipping.
22 Sep 2026
Bacterial canker in sweet cherry, caused by Pseudomonas syringae, is becoming more frequent in Washington. Learn the key symptoms, susceptible cultivars, predisposing conditions and management practices that can help reduce infection, tree decline and orchard losses.
